[ad_1]
A clbad action lawsuit was filed against five Canadian pharmaceutical companies alleging that the companies may have been negligent in the manufacture of drugs and in the quality control tests of their supplier's raw materials in China [19659002]. Health Canada has recalled 28 antihypertensive drugs from five generic brands that use the valsartan ingredient. The Chinese company that produces valsartan has reported contamination with N-nitrosodimethylamine (NDMA), which the International Agency for Research on Cancer has clbadified as a probable human carcinogen.
Zhejiang Huahai Pharmaceuticals, the Chinese company involved in the contamination, did not respond to a request for comments from CTV News
The recall could affect 4.4 million Canadians who were prescribed these drugs . A proposed clbad action lawsuit alleges that the five Canadian companies – Teva Canada Ltd., Sandoz Canada Inc., Pro Doc Limitee, Sanis Health Inc. and Sivem Pharmaceuticals ULC – could not have adequately tested their products.
take the pill that your doctor gives you. You pick it up at the pharmacy. You do not think anything will happen, "said patient Carla James at CTV News." It's just amazing. "
James is taking one of the drugs recalled for years and is now part of Proposed lawsuit She says that when the pharmacy called to say that there was a reminder about her prescription, she was shocked.
"I was terrified," she said. "I did not know what to do or what to think. All I could think of was, "I'd better go to my doctor (as soon as possible)."
Although James was able to find another prescription, it seems that D & D Others might not be so lucky. Reports suggest the recall has caused a worldwide shortage of many prescription drugs
The Canadian Pharmacists Association has compiled a list to help doctors and other prescribers find other options for their customers
. including how many drugs have been affected and for how long. The only report so far on how the carcinogen has penetrated the drugs suggests that it was the result of the "manufacturing process".
"What I would like to know that I have not been able to hear until now," says Jacinthe Leclerc, a medical researcher at Laval University in Quebec City.
"Companies will need to be transparent to the public, tell them how long the potentially contaminated pills … will be available to patients and what will they do to prevent other problems?" [19659002] those who may be affected:
- Continue taking your medications if they contain valsartan unless your doctor or pharmacist has told you to stop;
- Contact your doctor to see if the booster affects your medication; and
- If your medications are part of the recall, contact your doctor to discuss next steps.
With a report from CTV medical affairs expert Avis Favaro and producer Elizabeth St. Philip
[ad_2]
Source link
